Proteins on the surface of lipid storage droplets are crucial to droplet structure and function, but are poorly understood. Recent reports reveal a function for perilipins, major lipid droplet proteins in adipocytes, and show that caveolin proteins can accumulate on lipid droplets. Adipocytes and certain plant seeds contain large, well-developed lipid droplets that serve as storage depots for neutral lipids such as triacylglycerol and sterol esters. Droplets containing more modest amounts of neutral lipids are widespread among eukaryotic cells. Nevertheless we are just starting to understand the structure and dynamics of these ubiquitous structures [1, 2] . Lipid droplets are believed to form by coalescence of neutral lipids, which are synthesized in the endoplasmic reticulum (ER), into discs in the interior of the bilayer. The discs enlarge into spheres and eventually bud from the ER into the cytoplasm, becoming surrounded by a phospholipid monolayer derived from the ER.
Although the interior of lipid droplets consists entirely of neutral lipids, a number of proteins are present on the droplet surface. These proteins undoubtedly play key roles in lipid droplet structure and function, but very little is known about them. Recent studies [3] [4] [5] [6] in two areas extend our understanding of lipid droplet proteins. Brasaemle et al. [3] have discovered a function for perilipin, the major lipid droplet protein in adipocytes. And three recent papers [4] [5] [6] show that caveolin proteins, generally restricted to cell-surface caveolae and to the Golgi apparatus, can accumulate in lipid droplets. The physiological significance of this finding is not yet clear, but this surprising new localization may provide clues to how proteins are targeted to lipid droplets.
Perilipin is the major lipid-droplet protein in adipocytes, where it makes up 0.25 to 0.5% of total cell protein [1] . (Perilipin A, B, and C result from alternative splicing of a single perilipin gene.) Perilipin appears to be restricted to adipocytes and steroidogenic cells, which are also specialized for lipid storage. These properties suggest that perilipin plays an important role in lipid droplet dynamics, but its functions have not been clear. Brasaemle et al. [3] have now expressed perilipin A -the predominant adipocyte isoform -in 3T3-L1 pre-adipocytes, which normally lack the protein. As a result, lipid droplets acquired a perilipin coat, became more numerous and clustered together. Triacylglycerol levels were elevated 6-to 30-fold through a reduction in the lipid hydrolysis rate; there was no significant effect on the rate of lipid synthesis.
Despite the observed reduction in lipid hydrolysis rate, perilipin A does not directly inhibit cellular lipases when assayed in vitro. Instead, the authors [3] suggest that perilipin A sterically blocks access of hormone-sensitive lipase, which catalyzes the rate-limiting step in triacylglycerol hydrolysis, to the droplet surface ( Figure 1 ). Lipolysis is stimulated in vivo by adrenaline, through the activation of protein kinase A in response to elevated cAMP levels, and perilipin A is a major substrate for protein kinase A. Brasaemle et al. [3] propose the intriguing model whereby phosphorylation of perilipin A facilitates access of hormone-sensitive lipase to the droplet surface, thus stimulating lipolysis in a hormone-dependent manner.
Although perilipin can be a major protein component of lipid droplets -in adipocytes and steroidogenic cells - Role of perilipins in adipocyte lipid droplets [3] . Lipid droplets contain a neutral lipid core surrounded by a phospholipid monolayer. Perilipins associate with lipid droplets and could plausibly coat the entire surface [3] . Exogenous perilipin expression in 3T3-L1 pre-adipocytes retards triacylglycerol hydrolysis, possibly through sterically blocking access of hormone-sensitive lipase to the droplet surface. Proteins and lipids are not drawn to scale.
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Current Biology there are of course others. Three recent reports [4] [5] [6] now show that caveolins can also accumulate on the surface of lipid droplets (see also [7] ). Caveolins such as caveolins-1 and 2, which are widespread in mammalian cells, and the muscle-specific caveolin-3, form a coat that surrounds 50-100 nm flask-shaped invaginations of the plasma membrane called caveolae [8, 9] . Caveolae have been reported to function in endocytosis, signal transduction, growth control and cholesterol transport [8, 9] although it is not yet clear how these disparate roles are coordinated. Caveolins are localized primarily at the plasma membrane, with a smaller pool in the Golgi apparatus.
Pol et al. [6] show that amino-terminal truncation mutants of caveolins 1, 2 and 3 are targeted to lipid droplets. One of these mutants, Cav-3 DGV , is already known to be targeted to the early Golgi [10] . In this new study [6] , Cav-3 DGV is found in both the Golgi and lipid droplets. The Golgi pool disappears after cycloheximide treatment, suggesting that it is transient. In earlier work, the authors [11] showed that Cav-3 DGV has a dominant-negative effect on cholesterol transport to the cell surface, and inhibits H-Ras signaling by disrupting cholesterol-dependent plasma membrane rafts. In their recent study [6] , they use filipin staining to suggest that Cav-3 DGV expression redirects cholesterol from the plasma membrane to late endosomes [6] .
Fujimoto et al. [4] show that overexpressed caveolin-2 is targeted to lipid droplets. They suggest that the lipid droplet surface may be an important site of intracellular signaling. Consistent with this idea, mitogen-activated protein kinase and phosphatidylinositol 3-kinase localize to the lipid droplet surface in certain myeloid cells, which mobilize stored lipid to generate arachidonic acid used in eicosanoid synthesis [12, 13] .
We [5] have shown showed that Cav-KKSL -caveolin-1 with an ER retrieval sequence appended to the carboxyl terminus -is localized to lipid droplets as well as to the ER, and is often highly concentrated in the droplets. An internal-deletion mutant of caveolin-1 also accumulates in the droplets, as well as in the Golgi. Overexpressed caveolin-2 shows the same localization. Finally, treating cells with brefeldin A to block forward transport through the secretory pathway causes endogenous caveolin to accumulate in the droplets.
To unify these disparate results, we [5] propose that accumulation of caveolins to unusually high levels in the ER may be sufficient for lipid droplet targeting. This can explain the localization patterns reported in all three papers, if overexpressed caveolin-2 and the mutants fold poorly and are thus transported inefficiently through the secretory pathway. Caveolin-2 expressed in the absence of caveolin-1 is known to accumulate in the Golgi apparatus [7] , possibly reflecting inefficient transport. We do not yet know why caveolins accumulate in lipid droplets only under unusual circumstances. It is also not yet clear whether targeting of caveolin to lipid droplets is physiologically relevant. Even before its significance is determined, however, this novel localization may shed new light on general mechanisms of lipid droplet targeting.
Relatively few lipid droplet proteins are known, and very little is known about how they are targeted to the droplets. Structurally, lipid droplet proteins can be divided into at least two classes. The first includes perilipins and adipocyte differentiation-related protein -ADRP or adipophilina protein that is present on lipid droplets in most mammalian cells [1] . Proteins in this class are translated on free ribosomes and recruited to the droplets from the cytosol (unpublished data cited in [1] ). Lipid droplet association of some of these proteins, including perilipin and hormone-sensitive lipase, is reversible, and the proteins cycle between the cytosol and lipid droplets depending on the nutritional status of the cell [14] .
In contrast, membrane-spanning proteins do not seem to be present in lipid droplets. This is not surprising, as the phospholipid monolayer surrounding lipid droplets floats on a hydrophobic core. Proteins that have a hydrophilic domain on either side of a membrane bilayer could not easily be accommodated in this structure. Nevertheless, some lipid droplet proteins contain long hydrophobic amino acid sequences that are usually diagnostic of membranespanning domains. The best characterized of these are oleosins, proteins that coat lipid droplets in certain plant seeds and may protect droplets from coalescence during rehydration following desiccation [2] . Caveolins, which are co-translationally inserted into the ER in a signal recognition particle-dependent manner [15] , now join oleosins as integral lipid droplet proteins.
Caveolins and oleosins have strikingly similar topologies: both are comprised of two hydrophilic cytoplasmic domains that flank a central hydrophobic domain. An attractive model is that the hydrophobic domain penetrates into the phospholipid monolayer, and possibly into the neutral lipid core, while the hydrophilic domains extend into the cytoplasm. (Caveolins are thought to have a similar disposition in membranes, where the central hydrophobic domain is embedded in the bilayer.) This topology suggests a mechanism for delivery of these proteins to lipid droplets ( Figure 2 ). After synthesis, they could diffuse laterally between the ER proper and nascent lipid droplets that were still contained in the membrane. In this manner, the proteins could enter the droplets without exposing their hydrophobic domains to the cytosol. In contrast, transmembrane ER proteins would be excluded from the forming droplets (Figure 2 ). Although this model can explain how caveolins and oleosins gain access to lipid droplets, however, it does not explain how they are specifically targeted to the droplets and become concentrated there.
Sequences required for lipid droplet targeting of a few proteins have been identified [1, 2, 16] . However, no consensus has emerged, and these sequences have not illuminated the mechanism of targeting. Two classes of targeting mechanism can be imagined. Proteins could bind directly to the lipids in the droplet surface. Alternatively, they could bind to other droplet proteins. At least some lipid droplet proteins must interact directly with lipids. This is because lipid droplets, unlike membranes, are continuously synthesized de novo. No pre-existing compartment houses proteins that could serve as docking sites for new proteins.
How do proteins that interact directly with lipids distinguish the lipid droplet surface from the ER? The phospholipid monolayer surrounding lipid droplets might be expected to be a random sample of ER membrane, except for the lack of transmembrane proteins. The question applies to integral as well as peripheral proteins. If oleosins and caveolins can diffuse freely between the ER and the surface of forming droplets, why do they become highly concentrated in the droplets?
Caveolins may interact directly with droplet lipids. Indeed, if caveolins do not function in droplets, and are only mistargeted there under non-physiological circumstances, it would be surprising if specific interactions between caveolins and droplet proteins had evolved. It would seem more likely that caveolins are sometimes 'accidentally' targeted to the droplets through an affinity for the lipids there. This affinity may reflect a physiologically relevant association of caveolin with lipids elsewhere in the cell that, maybe coincidentally, are present in a similar state.
Caveolins have a high affinity for plasma membrane microdomains called lipid rafts [8, 9] . Rafts are characterized by the tight packing and high degree of order of their lipid acyl chains [17] . Could the affinity of caveolins for lipid droplets be related to their affinity for rafts? If so, it would suggest that lipids in the lipid droplet surface are more ordered than those in the ER. Lipid droplet-localized Cav-3 DGV is insoluble in cold non-ionic detergents, a hallmark of raft-associated proteins [6] . (As a cautionary note, however, the basis of lipid droplet detergent-insolubility is not as well understood as that of bilayers.) Some workers have found high levels of free cholesterol -a raft-promoting lipid -in the lipid droplet surface [18] , although others have not [7] .
If the lipid droplet surface exists in a different physical state than the ER membrane, then endogenous lipid droplet proteins, as well as caveolin, might use this property in targeting. The chemical and physical properties of the lipid droplet surface are not well understood. Contact with the underlying core might affect the packing of phospholipids in the monolayer. This might cause selective recruitment of certain lipids in the ER membrane to the surface of developing droplets. A better characterization of the lipid droplet surface will clearly be required to understand how proteins function there.
Figure 2
How caveolins and oleosins could enter lipid droplets. Synthesis of neutral lipids in the ER membrane causes the membrane to bulge, as the lipids accumulate in a disc in the center of the membrane and drive opposite monolayers apart. The droplet will eventually pinch off from the ER membrane into the cytoplasm, surrounded by an ERderived phospholipid monolayer. Transmembrane proteins should be excluded from forming droplets, as their membrane-spanning domains are too short to fit in the thickening bilayer. Caveolins and oleosins, by contrast, are free to diffuse between the ER membrane bilayer and the forming droplet, as they do not contain luminal hydrophilic domains.
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